“I married a wonderful man with a good income. He left his job due to health issues and suffered a massive stroke at 53.”
MarketWatch
I receive 10 calls a day promising me $15,000 loans at 8% interest. Are these legitimate offers?
“They insist that the details will be provided after they have carried out a soft credit check.”
We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?
“I don’t want to enter retirement owing six figures when we have the cash to clear it.”
George Foreman’s lavish Texas estate with 50-car garage is listed for $6 million
The sprawling Texas estate where boxing legend George Foreman spent the final decades of his life has hit the market for $6 million—offering a rare glimpse inside the private world of the heavyweight champion.
Bull markets tend to peak with a whimper, not a bang — but a 15% correction for the S&P 500 may be next
Unlike bear-market bottoms, which typically end with a spasm of despair as traders throw in the towel, bull-market tops are far more gradual and less dramatic.
Super Micro’s stock soars after surprise update — with Dell and HPE shares joining the rally
Super Micro unexpectedly disclosed that its revenue and profitability could be much stronger than originally anticipated.
Tesla’s stock rises as Elon Musk drops new clues about a possible SpaceX merger
Special committees at both companies are assessing merger prospects but a combination is no sure thing, Musk says.
Why SpaceX’s stock is surging — and lifting the broader AI universe along with it
SpaceX just gave Wall Street a big reason to believe in the AI boom as demand for its computing power is off the charts.
Walmart takes aim at Amazon and Costco with new membership program — but is it a good deal?
Some analysts question whether people will actually take advantage of Walmart’s new bundle, and how easy it is to make sense of the benefits.
Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.
For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.